Close Menu

NEW YORK (GenomeWeb) – Genetic Technologies said today that its share purchase plan raised A$257,500 (US$211,000). 

The purchase plan closed on Dec. 22 and the company received applications for about 19 million shares. The new shares were issued today, Genetic Technologies said. Proceeds will be used to expand the commercialization of its BrevaGenplus breast cancer test and for general working capital. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.